OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome
Theodoros Karantanos, Amy E. DeZern
Best Practice & Research Clinical Haematology (2021) Vol. 34, Iss. 2, pp. 101280-101280
Closed Access | Times Cited: 14
Theodoros Karantanos, Amy E. DeZern
Best Practice & Research Clinical Haematology (2021) Vol. 34, Iss. 2, pp. 101280-101280
Closed Access | Times Cited: 14
Showing 14 citing articles:
Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms
Sanam Loghavi, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, et al.
Modern Pathology (2023) Vol. 37, Iss. 2, pp. 100397-100397
Closed Access | Times Cited: 17
Sanam Loghavi, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, et al.
Modern Pathology (2023) Vol. 37, Iss. 2, pp. 100397-100397
Closed Access | Times Cited: 17
Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience
Giulia Calabretto, Enrico Attardi, Antonella Teramo, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1947-1950
Open Access | Times Cited: 18
Giulia Calabretto, Enrico Attardi, Antonella Teramo, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1947-1950
Open Access | Times Cited: 18
Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
Phaedon D. Zavras, Ilias Sinanidis, Panagiotis Tsakiroglou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5018-5018
Open Access | Times Cited: 11
Phaedon D. Zavras, Ilias Sinanidis, Panagiotis Tsakiroglou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5018-5018
Open Access | Times Cited: 11
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study
Ying‐Ying Ma, Zeliang Wei, Ya‐Jing Xu, et al.
Cancer (2023) Vol. 129, Iss. 13, pp. 2013-2022
Closed Access | Times Cited: 10
Ying‐Ying Ma, Zeliang Wei, Ya‐Jing Xu, et al.
Cancer (2023) Vol. 129, Iss. 13, pp. 2013-2022
Closed Access | Times Cited: 10
Navigating the dynamic landscape of lower-risk MDS: Advances and emerging insights
Alain Mina, Yazan F. Madanat, Yasmin Abaza, et al.
Blood Reviews (2025), pp. 101301-101301
Closed Access
Alain Mina, Yazan F. Madanat, Yasmin Abaza, et al.
Blood Reviews (2025), pp. 101301-101301
Closed Access
BMT for Myelodysplastic Syndrome: When and Where and How
Akriti G Jain, Hany Elmariah
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 12
Akriti G Jain, Hany Elmariah
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 12
HALP score as a novel prognostic factor for patients with myelodysplastic syndromes
Vildan Gürsoy, Sevil Sadri, Hatice Demirci Küçükelyas, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Vildan Gürsoy, Sevil Sadri, Hatice Demirci Küçükelyas, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine
Theodoros Karantanos, Patric Teodorescu, Marios Arvanitis, et al.
Haematologica (2022) Vol. 108, Iss. 7, pp. 1886-1899
Open Access | Times Cited: 10
Theodoros Karantanos, Patric Teodorescu, Marios Arvanitis, et al.
Haematologica (2022) Vol. 108, Iss. 7, pp. 1886-1899
Open Access | Times Cited: 10
Clinical significance of prognostic nutritional index in myelodysplastic syndrome
Yue Chen, Junhui Wang, Jingjing Ma, et al.
Hematology (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 3
Yue Chen, Junhui Wang, Jingjing Ma, et al.
Hematology (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 3
Prognostic value of the controlling nutritional status score in patients with myelodysplastic syndromes
Qiuni Chen, Kankan Chen, Sumei Wang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 3
Qiuni Chen, Kankan Chen, Sumei Wang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 3
Extracellular Vesicles in Myeloid Neoplasms
Christina Karantanou, Valentina R. Minciacchi, Theodoros Karantanos
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8827-8827
Open Access | Times Cited: 3
Christina Karantanou, Valentina R. Minciacchi, Theodoros Karantanos
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8827-8827
Open Access | Times Cited: 3
Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options
Ahmed Alobaidi, Ahmed Albadry, Anne Murray
Cureus (2023)
Open Access | Times Cited: 1
Ahmed Alobaidi, Ahmed Albadry, Anne Murray
Cureus (2023)
Open Access | Times Cited: 1
First-Trimester Preeclampsia-Induced Disturbance in Maternal Blood Serum Proteome: A Pilot Study
Natalia Starodubtseva, Alisa Tokareva, А. С. Кононихин, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10653-10653
Open Access
Natalia Starodubtseva, Alisa Tokareva, А. С. Кононихин, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10653-10653
Open Access
Retrospective Evaluation of Patients Who Underwent Allogeneic Stem Cell Transplantation for Bone Marrow Failure
Tuba Ersal, Vildan Özkocaman
Turkish Journal of Internal Medicine (2023) Vol. 5, Iss. 4, pp. 262-270
Open Access
Tuba Ersal, Vildan Özkocaman
Turkish Journal of Internal Medicine (2023) Vol. 5, Iss. 4, pp. 262-270
Open Access
